By G HossainPosted on July 25, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The European Union’s health regulatory agency did not endorse approving Elevidys for ambulatory patients with Duchenne muscular dystrophy. Sarepta Fallout Continues With EU’s Negative Opinion of Elevidys in Ambulatory Patients Post navigation Adicet’s Pipeline Optimization Push Claims 30% of WorkforceEli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines